Back to search

Article

Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’s

2020-07-04

Abstract excerpt

Ca 2+ entry into nigrostriatal dopamine (DA) neurons and axons via L-type voltage-gated Ca 2+ channels (LTCCs) contributes respectively to pacemaker activity and DA release, and has long been thought to contribute to vulnerability to degeneration in Parkinson’s disease. LTCC function is greater in DA axons and neurons from substantia nigra pars compacta than from ventral tegmental area, but this is not explained...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d3ad379-beb2-5d92-888b-e35a312ab03d
DOI
10.1101/2020.07.03.186411
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson’sDOI 10.1101/2020.07.03.186411
Select a neighboring publication to make it the new centre.